Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier García-Moll

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Revista Espanola De Cardiologia|March 16, 2006
[Ischemic heart disease: 2005 update]Alfredo Bardají, Joaquín Alonso, Xavier García-Moll, et al.
Revista Espanola De Cardiologia|March 14, 2007
[Ischemic heart disease: 2006 update]Xavier García-Moll, Alfredo Bardají, Joaquín Alonso, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2014
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in SpainJosé L Zamorano, Xavier García-Moll, Roberto Ferrari, et al.
Journal of Proteome Research|November 4, 2010
Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarctionJudit Cubedo, Teresa Padró, Xavier García-Moll, et al.
Revista Espanola De Cardiologia|May 25, 2007
[Intermediate coronary care units: rationale, infrastructure, equipment, and referral criteria]Joaquín J Alonso, Ginés Sanz, Josep Guindo, et al.
Expert Review of Cardiovascular Therapy|February 28, 2024
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trialsXavier García-Moll, Francesco Croci, Alexandra Solé, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 22, 2019
Valvular heart disease and calcification in CKD: more common than appreciatedPablo Ureña-Torres, Luis D'Marco, Paolo Raggi, et al.
Future Cardiology|October 23, 2024
Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology settingJuan José Gómez Doblas, Xavier García-Moll, Ramón Bover Freire, et al.
Cardiovascular Diagnosis and Therapy|November 9, 2023
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO studyCarlos Escobar, Ramón Bover Freire, Xavier García-Moll Marimón, et al.
Expert Review of Clinical Pharmacology|July 5, 2019
Role of rivaroxaban in the prevention of atherosclerotic eventsMarcelo Sanmartín, Sergi Bellmunt, Juan Cosín-Sales, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Revista Espanola De Cardiologia|March 16, 2006
[Ischemic heart disease: 2005 update]Alfredo Bardají, Joaquín Alonso, Xavier García-Moll, et al.
Revista Espanola De Cardiologia|March 14, 2007
[Ischemic heart disease: 2006 update]Xavier García-Moll, Alfredo Bardají, Joaquín Alonso, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2014
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in SpainJosé L Zamorano, Xavier García-Moll, Roberto Ferrari, et al.
Journal of Proteome Research|November 4, 2010
Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarctionJudit Cubedo, Teresa Padró, Xavier García-Moll, et al.
Revista Espanola De Cardiologia|May 25, 2007
[Intermediate coronary care units: rationale, infrastructure, equipment, and referral criteria]Joaquín J Alonso, Ginés Sanz, Josep Guindo, et al.
Expert Review of Cardiovascular Therapy|February 28, 2024
A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trialsXavier García-Moll, Francesco Croci, Alexandra Solé, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 22, 2019
Valvular heart disease and calcification in CKD: more common than appreciatedPablo Ureña-Torres, Luis D'Marco, Paolo Raggi, et al.
Future Cardiology|October 23, 2024
Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology settingJuan José Gómez Doblas, Xavier García-Moll, Ramón Bover Freire, et al.
Cardiovascular Diagnosis and Therapy|November 9, 2023
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO studyCarlos Escobar, Ramón Bover Freire, Xavier García-Moll Marimón, et al.
Expert Review of Clinical Pharmacology|July 5, 2019
Role of rivaroxaban in the prevention of atherosclerotic eventsMarcelo Sanmartín, Sergi Bellmunt, Juan Cosín-Sales, et al.
Pageof 2